Physicochemical Compatibility of Propofol-Lidocaine Mixture
To examine the physicochemical stability of combinations of propofol-lidocaine mixtures frequently used in clinical practice, we added lidocaine 5, 10, 20, or 40 mg to commercially available 1% propofol 20 mL. To assess chemical stability, propofol concentrations were determined by gas chromatograph...
Gespeichert in:
Veröffentlicht in: | Anesthesia and analgesia 2003-12, Vol.97 (6), p.1646-1651 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1651 |
---|---|
container_issue | 6 |
container_start_page | 1646 |
container_title | Anesthesia and analgesia |
container_volume | 97 |
creator | Masaki, Yoko Tanaka, Makoto Nishikawa, Toshiaki |
description | To examine the physicochemical stability of combinations of propofol-lidocaine mixtures frequently used in clinical practice, we added lidocaine 5, 10, 20, or 40 mg to commercially available 1% propofol 20 mL. To assess chemical stability, propofol concentrations were determined by gas chromatography assay for 24 h after preparation of the mixture. In addition, scanning electron microscopy was used to determine the maximum detectable droplet size in randomly selected fields. Macroscopically, separate, colorless layers were first seen at 3 and 24 h after the addition of 40 and 20 mg of lidocaine to propofol, respectively, whereas the mixture with 5 or 10 mg of lidocaine was macroscopically stable. Propofol concentrations in the mixture with 40 mg of lidocaine decreased linearly and significantly from 4 to 24 h after preparation, whereas those combined with other lidocaine doses were unchanged compared with baseline concentrations. Scanning electron microscopy showed that droplets with diameters ≥5 μm first appeared 30 min after the addition of 40 mg of lidocaine to propofol, and the emulsion droplets were enlarged in a time- and dose-dependent fashion. Our results indicate that the addition of lidocaine to propofol results in a coalescence of oil droplets, which finally proceeds to a visible separate layer. Depending on the dose of lidocaine and the duration between its preparation and administration, this combination may pose the risk of pulmonary embolism. |
doi_str_mv | 10.1213/01.ANE.0000087802.50796.FB |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71392814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71392814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5080-696ad58aabe49d769a97475d2fc8728c1579d10b66de3bce596bec696b4e67013</originalsourceid><addsrcrecordid>eNpFkV1v2yAUhlG1as3a_YUqmrTd2eXDfG1XbdS0lbK1F9s1wvhYYcMhA1td_v1IEylIgBDPew56QOgTwTWhhN1gUt_-uK_xfiipMK05llrUy7szNCOcikpyrd6hWblnFdVaX6APOf8uR4KVeI8uSCMY44zP0LeX9S57F90aBu9smC_isLWjb33w424e-_lLitvYx1CtfBed9RuYf_f_xinBFTrvbcjw8bhfol_L-5-Lx2r1_PC0uF1VjmOFK6GF7biytoVGd1Joq2UjeUd7pyRVjnCpO4JbITpgrQOuRQuupNoGhMSEXaIvh7rbFP9OkEcz-OwgBLuBOGUjCdNUkaaAXw-gSzHnBL3ZJj_YtDMEm706g4kp6sxJnXlTZ5Z3JXx97DK1A3Sn6NFVAT4fAZuLqT7ZjfP5xHHGMKX75zYH7jWGEVL-E6ZXSGYNNozrQ2vOdEXL55Cy4KpMitl__D-Gfw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71392814</pqid></control><display><type>article</type><title>Physicochemical Compatibility of Propofol-Lidocaine Mixture</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>EZB Electronic Journals Library</source><source>Journals@Ovid Complete</source><creator>Masaki, Yoko ; Tanaka, Makoto ; Nishikawa, Toshiaki</creator><creatorcontrib>Masaki, Yoko ; Tanaka, Makoto ; Nishikawa, Toshiaki</creatorcontrib><description>To examine the physicochemical stability of combinations of propofol-lidocaine mixtures frequently used in clinical practice, we added lidocaine 5, 10, 20, or 40 mg to commercially available 1% propofol 20 mL. To assess chemical stability, propofol concentrations were determined by gas chromatography assay for 24 h after preparation of the mixture. In addition, scanning electron microscopy was used to determine the maximum detectable droplet size in randomly selected fields. Macroscopically, separate, colorless layers were first seen at 3 and 24 h after the addition of 40 and 20 mg of lidocaine to propofol, respectively, whereas the mixture with 5 or 10 mg of lidocaine was macroscopically stable. Propofol concentrations in the mixture with 40 mg of lidocaine decreased linearly and significantly from 4 to 24 h after preparation, whereas those combined with other lidocaine doses were unchanged compared with baseline concentrations. Scanning electron microscopy showed that droplets with diameters ≥5 μm first appeared 30 min after the addition of 40 mg of lidocaine to propofol, and the emulsion droplets were enlarged in a time- and dose-dependent fashion. Our results indicate that the addition of lidocaine to propofol results in a coalescence of oil droplets, which finally proceeds to a visible separate layer. Depending on the dose of lidocaine and the duration between its preparation and administration, this combination may pose the risk of pulmonary embolism.</description><identifier>ISSN: 0003-2999</identifier><identifier>EISSN: 1526-7598</identifier><identifier>DOI: 10.1213/01.ANE.0000087802.50796.FB</identifier><identifier>PMID: 14633535</identifier><identifier>CODEN: AACRAT</identifier><language>eng</language><publisher>Hagerstown, MD: International Anesthesia Research Society</publisher><subject>Anesthetics, Intravenous - chemistry ; Anesthetics, Local - chemistry ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Chemical Phenomena ; Chemistry, Physical ; Chromatography, Gas ; Drug Incompatibility ; Lidocaine - chemistry ; Medical sciences ; Microscopy, Electron, Scanning ; Neuropharmacology ; Pharmacology. Drug treatments ; Propofol - chemistry</subject><ispartof>Anesthesia and analgesia, 2003-12, Vol.97 (6), p.1646-1651</ispartof><rights>International Anesthesia Research Society</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5080-696ad58aabe49d769a97475d2fc8728c1579d10b66de3bce596bec696b4e67013</citedby><cites>FETCH-LOGICAL-c5080-696ad58aabe49d769a97475d2fc8728c1579d10b66de3bce596bec696b4e67013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00000539-200312000-00020$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4594,27903,27904,65210</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15330221$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14633535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masaki, Yoko</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Nishikawa, Toshiaki</creatorcontrib><title>Physicochemical Compatibility of Propofol-Lidocaine Mixture</title><title>Anesthesia and analgesia</title><addtitle>Anesth Analg</addtitle><description>To examine the physicochemical stability of combinations of propofol-lidocaine mixtures frequently used in clinical practice, we added lidocaine 5, 10, 20, or 40 mg to commercially available 1% propofol 20 mL. To assess chemical stability, propofol concentrations were determined by gas chromatography assay for 24 h after preparation of the mixture. In addition, scanning electron microscopy was used to determine the maximum detectable droplet size in randomly selected fields. Macroscopically, separate, colorless layers were first seen at 3 and 24 h after the addition of 40 and 20 mg of lidocaine to propofol, respectively, whereas the mixture with 5 or 10 mg of lidocaine was macroscopically stable. Propofol concentrations in the mixture with 40 mg of lidocaine decreased linearly and significantly from 4 to 24 h after preparation, whereas those combined with other lidocaine doses were unchanged compared with baseline concentrations. Scanning electron microscopy showed that droplets with diameters ≥5 μm first appeared 30 min after the addition of 40 mg of lidocaine to propofol, and the emulsion droplets were enlarged in a time- and dose-dependent fashion. Our results indicate that the addition of lidocaine to propofol results in a coalescence of oil droplets, which finally proceeds to a visible separate layer. Depending on the dose of lidocaine and the duration between its preparation and administration, this combination may pose the risk of pulmonary embolism.</description><subject>Anesthetics, Intravenous - chemistry</subject><subject>Anesthetics, Local - chemistry</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Chromatography, Gas</subject><subject>Drug Incompatibility</subject><subject>Lidocaine - chemistry</subject><subject>Medical sciences</subject><subject>Microscopy, Electron, Scanning</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Propofol - chemistry</subject><issn>0003-2999</issn><issn>1526-7598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkV1v2yAUhlG1as3a_YUqmrTd2eXDfG1XbdS0lbK1F9s1wvhYYcMhA1td_v1IEylIgBDPew56QOgTwTWhhN1gUt_-uK_xfiipMK05llrUy7szNCOcikpyrd6hWblnFdVaX6APOf8uR4KVeI8uSCMY44zP0LeX9S57F90aBu9smC_isLWjb33w424e-_lLitvYx1CtfBed9RuYf_f_xinBFTrvbcjw8bhfol_L-5-Lx2r1_PC0uF1VjmOFK6GF7biytoVGd1Joq2UjeUd7pyRVjnCpO4JbITpgrQOuRQuupNoGhMSEXaIvh7rbFP9OkEcz-OwgBLuBOGUjCdNUkaaAXw-gSzHnBL3ZJj_YtDMEm706g4kp6sxJnXlTZ5Z3JXx97DK1A3Sn6NFVAT4fAZuLqT7ZjfP5xHHGMKX75zYH7jWGEVL-E6ZXSGYNNozrQ2vOdEXL55Cy4KpMitl__D-Gfw</recordid><startdate>20031201</startdate><enddate>20031201</enddate><creator>Masaki, Yoko</creator><creator>Tanaka, Makoto</creator><creator>Nishikawa, Toshiaki</creator><general>International Anesthesia Research Society</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031201</creationdate><title>Physicochemical Compatibility of Propofol-Lidocaine Mixture</title><author>Masaki, Yoko ; Tanaka, Makoto ; Nishikawa, Toshiaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5080-696ad58aabe49d769a97475d2fc8728c1579d10b66de3bce596bec696b4e67013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Anesthetics, Intravenous - chemistry</topic><topic>Anesthetics, Local - chemistry</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Chromatography, Gas</topic><topic>Drug Incompatibility</topic><topic>Lidocaine - chemistry</topic><topic>Medical sciences</topic><topic>Microscopy, Electron, Scanning</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Propofol - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masaki, Yoko</creatorcontrib><creatorcontrib>Tanaka, Makoto</creatorcontrib><creatorcontrib>Nishikawa, Toshiaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masaki, Yoko</au><au>Tanaka, Makoto</au><au>Nishikawa, Toshiaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physicochemical Compatibility of Propofol-Lidocaine Mixture</atitle><jtitle>Anesthesia and analgesia</jtitle><addtitle>Anesth Analg</addtitle><date>2003-12-01</date><risdate>2003</risdate><volume>97</volume><issue>6</issue><spage>1646</spage><epage>1651</epage><pages>1646-1651</pages><issn>0003-2999</issn><eissn>1526-7598</eissn><coden>AACRAT</coden><abstract>To examine the physicochemical stability of combinations of propofol-lidocaine mixtures frequently used in clinical practice, we added lidocaine 5, 10, 20, or 40 mg to commercially available 1% propofol 20 mL. To assess chemical stability, propofol concentrations were determined by gas chromatography assay for 24 h after preparation of the mixture. In addition, scanning electron microscopy was used to determine the maximum detectable droplet size in randomly selected fields. Macroscopically, separate, colorless layers were first seen at 3 and 24 h after the addition of 40 and 20 mg of lidocaine to propofol, respectively, whereas the mixture with 5 or 10 mg of lidocaine was macroscopically stable. Propofol concentrations in the mixture with 40 mg of lidocaine decreased linearly and significantly from 4 to 24 h after preparation, whereas those combined with other lidocaine doses were unchanged compared with baseline concentrations. Scanning electron microscopy showed that droplets with diameters ≥5 μm first appeared 30 min after the addition of 40 mg of lidocaine to propofol, and the emulsion droplets were enlarged in a time- and dose-dependent fashion. Our results indicate that the addition of lidocaine to propofol results in a coalescence of oil droplets, which finally proceeds to a visible separate layer. Depending on the dose of lidocaine and the duration between its preparation and administration, this combination may pose the risk of pulmonary embolism.</abstract><cop>Hagerstown, MD</cop><pub>International Anesthesia Research Society</pub><pmid>14633535</pmid><doi>10.1213/01.ANE.0000087802.50796.FB</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2999 |
ispartof | Anesthesia and analgesia, 2003-12, Vol.97 (6), p.1646-1651 |
issn | 0003-2999 1526-7598 |
language | eng |
recordid | cdi_proquest_miscellaneous_71392814 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; EZB Electronic Journals Library; Journals@Ovid Complete |
subjects | Anesthetics, Intravenous - chemistry Anesthetics, Local - chemistry Anesthetics. Neuromuscular blocking agents Biological and medical sciences Chemical Phenomena Chemistry, Physical Chromatography, Gas Drug Incompatibility Lidocaine - chemistry Medical sciences Microscopy, Electron, Scanning Neuropharmacology Pharmacology. Drug treatments Propofol - chemistry |
title | Physicochemical Compatibility of Propofol-Lidocaine Mixture |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A25%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physicochemical%20Compatibility%20of%20Propofol-Lidocaine%20Mixture&rft.jtitle=Anesthesia%20and%20analgesia&rft.au=Masaki,%20Yoko&rft.date=2003-12-01&rft.volume=97&rft.issue=6&rft.spage=1646&rft.epage=1651&rft.pages=1646-1651&rft.issn=0003-2999&rft.eissn=1526-7598&rft.coden=AACRAT&rft_id=info:doi/10.1213/01.ANE.0000087802.50796.FB&rft_dat=%3Cproquest_cross%3E71392814%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71392814&rft_id=info:pmid/14633535&rfr_iscdi=true |